A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study. Germaine, H., Hannah, C., Emily, A., Caroline, T., Jo, R., Cécile, D., Stephan, D., Stefaan, V. D. S., & Nancy, T. Technical Report Belgian Health Care Knowledge Centre (KCE), Brussels, 2014.
A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study [pdf]Paper  bibtex   

Downloads: 0